Designer DNA nanostructures for viral inhibition

Shaokang Ren, Keith Fraser, Lili Kuo, Neha Chauhan, Addison T. Adrian, Fuming Zhang, Robert J. Linhardt, Paul S. Kwon, Xing Wang

Published: 2022-01-09 DOI: 10.1038/s41596-021-00641-y

antiviral efficacy

DNA nanostructures

viral inhibition

dengue virus

structural data

AI 解读

Efficient and safe single-cell cloning of human pluripotent stem cells using the CEPT cocktail

Profiling native pulmonary basement membrane stiffness using atomic force microscopy

Genetic circuit design automation with Cello 2.0

Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages

Scalable dual-omics profiling with single-nucleus chromatin accessibility and mRNA expression sequencing 2 (SNARE-seq2)

A practical guide to scanning light-field microscopy with digital adaptive optics

Effective high-throughput isolation of fully human antibodies targeting infectious pathogens

Improved sampling and DNA extraction procedures for microbiome analysis in food-processing environments

MOF-derived nanoporous carbons with diverse tunable nanoarchitectures

Tutorial: a statistical genetics guide to identifying HLA alleles driving complex disease

查看全部

Sections

Figures

References

Emerging viral diseases can substantially threaten national and global public health. Central to our ability to successfully tackle these diseases is the need to quickly detect the causative virus and neutralize it efficiently. Here we present the rationa
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- References
- References
References
ACKNOWLEDGMENTS

Auvinen, H. et al. Protein coating of DNA nanostructures for enhanced stability and immunocompatibility. Adv. Healthc. Mater. 6 (2017).
Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687–695 (2012).
Shrestha, S. S. et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010). Clin. Infect. Dis. 52, S75–S82 (2011).
Ali, M. G. et al. Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview. Immunol. Res. 68, 325–339 (2020).
Tirado, S. M. & Yoon, K. J. Antibody-dependent enhancement of virus infection and disease. Viral Immunol. 16, 69–86 (2003).
Whitehead, S. S., Blaney, J. E., Durbin, A. P. & Murphy, B. R. Prospects for a dengue virus vaccine. Nat. Rev. Microbiol. 5, 518–528 (2007).
Prasad, B. V. & Schmid, M. F. Principles of virus structural organization. Adv. Exp. Med. Biol. 726, 17–47 (2012).
Kwon, P. S. et al. Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition. Nat. Chem. 12, 26–35 (2020).
Fibriansah, G. et al. Structural changes in dengue virus when exposed to a temperature of 37 degrees C. J. Virol. 87, 7585–7592 (2013).
Kosuri, S. & Church, G. M. Large-scale de novo DNA synthesis: technologies and applications. Nat. Methods 11, 499–507 (2014).
Praetorius, F. et al. Biotechnological mass production of DNA origami. Nature 552, 84–87 (2017).
Ducani, C., Kaul, C., Moche, M., Shih, W. M. & Hogberg, B. Enzymatic production of ‘monoclonal stoichiometric’ single-stranded DNA oligonucleotides. Nat. Methods 10, 647–652 (2013).
Lin, C. et al. In vivo cloning of artificial DNA nanostructures. Proc. Natl Acad. Sci. USA 105, 17626–17631 (2008).
Seeman, N. C. Nucleic acid junctions and lattices. J. Theor. Biol. 99, 237–247 (1982).
Chandrasekaran, A. R. & Zhuo, R. A ‘tile’ tale: hierarchical self-assembly of DNA lattices. Appl. Mater. Today 2, 7–16 (2016).
Duan, J., Wang, X. & Kizer, M. E. Biotechnological and therapeutic applications of natural nucleic acid structural motifs. Top. Curr. Chem. 378, 26 (2020).
Chao, J. et al. Programming DNA origami assembly for shape-resolved nanomechanical imaging labels. Nat. Protoc. 13, 1569–1585 (2018).
Lanphere, C. et al. Design, assembly, and characterization of membrane-spanning DNA nanopores. Nat. Protoc. 16, 86–130 (2021).
Sigl, C. et al. Programmable icosahedral shell system for virus trapping. Nat. Mater. 20, 1281–1289 (2021).
Chauhan, N. & Wang, X. Nanocages for virus inhibition. Nat. Mater. 20, 1176–1177 (2021).
Kuzuya, A., Sakai, Y., Yamazaki, T., Xu, Y. & Komiyama, M. Nanomechanical DNA origami ‘single-molecule beacons’ directly imaged by atomic force microscopy. Nat. Commun. 2, 449 (2011).
Nikolovska-Coleska, Z. Studying protein–protein interactions using surface plasmon resonance. Methods Mol. Biol. 1278, 109–138 (2015).
Drescher, D. G., Selvakumar, D. & Drescher, M. J. Analysis of protein interactions by surface plasmon resonance. Adv. Protein Chem. Struct. Biol. 110, 1–30 (2018).
Douzi, B. Protein–protein interactions: surface plasmon resonance. Methods Mol. Biol. 1615, 257–275 (2017).
Rath, P. P., Anand, G. & Agarwal, S. Surface plasmon resonance analysis of the protein–protein binding specificity using Autolab ESPIRIT. Bio Protoc. 10, e3519 (2020).
Baer, A. & Kehn-Hall, K. Viral concentration determination through plaque assays: using traditional and novel overlay systems. J. Vis. Exp. e52065 (2014).
Mendoza, E. J., Manguiat, K., Wood, H. & Drebot, M. Two detailed plaque assay protocols for the quantification of infectious SARS-CoV-2. Curr. Protoc. Microbiol. 57, ecpmc105 (2020).
Kwon, S. J. et al. Nanostructured glycan architecture is important in the inhibition of influenza A virus infection. Nat. Nanotechnol. 12, 48–54 (2017).
Nie, C. et al. Spiky nanostructures with geometry-matching topography for virus inhibition. Nano Lett. 20, 5367–5375 (2020).
Lauster, D. et al. Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry. Nat. Nanotechnol. 15, 373–379 (2020).
King, D. J. & Noss, R. R. Toxicity of polyacrylamide and acrylamide monomer. Rev. Environ. Health 8, 3–16 (1989).
Malik, N. et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control Release 65, 133–148 (2000).
Ahmad, K. M., Xiao, Y. & Soh, H. T. Selection is more intelligent than design: improving the affinity of a bivalent ligand through directed evolution. Nucleic Acids Res 40, 11777–11783 (2012).
Strauch, E. M. et al. Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site. Nat. Biotechnol. 35, 667–671 (2017).
Mei, Q. A. et al. Stability of DNA origami nanoarrays in cell lysate. Nano Lett. 11, 1477–1482 (2011).
Hahn, J., Wickham, S. F. J., Shih, W. M. & Perrault, S. D. Addressing the instability of DNA nanostructures in tissue culture. ACS Nano 8, 8765–8775 (2014).
Agarwal, N. P., Matthies, M., Gur, F. N., Osada, K. & Schmidt, T. L. Block copolymer micellization as a protection strategy for DNA origami. Angew. Chem. Int. Ed. Engl. 56, 5460–5464 (2017).
Perrault, S. D. & Shih, W. M. Virus-inspired membrane encapsulation of DNA nanostructures to achieve in vivo stability. ACS Nano 8, 5132–5140 (2014).
Li, S. et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat. Biotechnol. 36, 258–264 (2018).
Kizer, M. E. et al. Hydroporator: a hydrodynamic cell membrane perforator for high-throughput vector-free nanomaterial intracellular delivery and DNA origami biostability evaluation. Lab Chip 19, 1747–1754 (2019).
Jiang, D. et al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat. Biomed. Eng. 2, 865–877 (2018).
Kim, Y. & Yin, P. Enhancing biocompatible stability of DNA nanostructures using dendritic oligonucleotides and brick motifs. Angew. Chem. Int. Ed. Engl. 59, 700–703 (2020).
Gerling, T., Kube, M., Kick, B. & Dietz, H. Sequence-programmable covalent bonding of designed DNA assemblies. Sci. Adv. 4, eaau1157 (2018).
Rothemund, P. W. Folding DNA to create nanoscale shapes and patterns. Nature 440, 297–302 (2006).
Chandrasekaran, A. R., Anderson, N., Kizer, M., Halvorsen, K. & Wang, X. Beyond the fold: emerging biological applications of DNA origami. Chembiochem 17, 1081–1089 (2016).
Wilner, O. I. & Willner, I. Functionalized DNA nanostructures. Chem. Rev. 112, 2528–2556 (2012).
Shaw, A. et al. Spatial control of membrane receptor function using ligand nanocalipers. Nat. Methods 11, 841–846 (2014).
Shaw, A. et al. Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies. Nat. Nanotechnol. 14, 184–190 (2019).
Veneziano, R. et al. Role of nanoscale antigen organization on B-cell activation probed using DNA origami. Nat. Nanotechnol. 15, 716–723 (2020).
Lee, H. et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7, 389–393 (2012).
Klinman, D. M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249–258 (2004).
Liu, X. et al. A DNA nanostructure platform for directed assembly of synthetic vaccines. Nano Lett. 12, 4254–4259 (2012).
Ponnuswamy, N. et al. Oligolysine-based coating protects DNA nanostructures from low-salt denaturation and nuclease degradation. Nat. Commun. 8, 15654 (2017).
Anastassacos, F. M., Zhao, Z., Zeng, Y. & Shih, W. M. Glutaraldehyde cross-linking of oligolysines coating DNA origami greatly reduces susceptibility to nuclease degradation. J. Am. Chem. Soc. 142, 3311–3315 (2020).
Ramakrishnan, S., Ijas, H., Linko, V. & Keller, A. Structural stability of DNA origami nanostructures under application-specific conditions. Comput. Struct. Biotechnol. J. 16, 342–349 (2018).
Bila, H., Kurisinkal, E. E. & Bastings, M. M. C. Engineering a stable future for DNA-origami as a biomaterial. Biomater. Sci. 7, 532–541 (2019).
Chandrasekaran, A. R. Nuclease resistance of DNA nanostructures. Nat. Rev. Chem. 5, 225–239 (2021).
Kick, B., Praetorius, F., Dietz, H. & Weuster-Botz, D. Efficient production of single-stranded phage DNA as scaffolds for DNA origami. Nano Lett. 15, 4672–4676 (2015).
Palluk, S. et al. De novo DNA synthesis using polymerase-nucleotide conjugates. Nat. Biotechnol. 36, 645–650 (2018).
Deng, Y. et al. Intracellular delivery of nanomaterials via an inertial microfluidic cell hydroporator. Nano Lett. 18, 2705–2710 (2018).
Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818–822 (1990).
Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990).
Robertson, D. L. & Joyce, G. F. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344, 467–468 (1990).
Kizer, M. E., Linhardt, R. J., Chandrasekaran, A. R. & Wang, X. A molecular hero suit for in vitro and in vivo DNA nanostructures. Small 15, e1805386 (2019).
Ke, Y., Castro, C. & Choi, J. H. Structural DNA nanotechnology: artificial nanostructures for biomedical research. Annu. Rev. Biomed. Eng. 20, 375–401 (2018).
Bujold, K. E., Lacroix, A. & Sleiman, H. F. DNA nanostructures at the interface with biology. Chem 4, 495–521 (2018).
Jorge, A. F. & Eritja, R. Overview of DNA self-assembling: progresses in biomedical applications. Pharmaceutics 10, 268 (2018).
Udomprasert, A. & Kangsamaksin, T. DNA origami applications in cancer therapy. Cancer Sci. 108, 1535–1543 (2017).
Xu, W. et al. Functional nucleic acid nanomaterials: development, properties, and applications. Angew. Chem. Int. Ed. Engl. (2019).
Weng, Y. et al. Improved nucleic acid therapy with advanced nanoscale biotechnology. Mol. Ther. Nucleic Acids 19, 581–601 (2019).
Kaur, H., Bruno, J. G., Kumar, A. & Sharma, T. K. Aptamers in the therapeutics and diagnostics pipelines. Theranostics 8, 4016–4032 (2018).
Shum, K. T., Zhou, J. & Rossi, J. J. Aptamer-based therapeutics: new approaches to combat human viral diseases. Pharmaceuticals 6, 1507–1542 (2013).
Keller, A. & Linko, V. Challenges and perspectives of DNA nanostructures in biomedicine. Angew. Chem. Int. Ed. Engl. 59, 15818–15833 (2020).
Jiang, S., Ge, Z., Mou, S., Yan, H. & Fan, C. Designer DNA nanostructures for therapeutics. Chem 7, 1156–1179 (2021).
Zeng, Y., Nixon, R. L., Liu, W. & Wang, R. The applications of functionalized DNA nanostructures in bioimaging and cancer therapy. Biomaterials 268, 120560 (2021).
Wang, H., Luo, D., Wang, H., Wang, F. & Liu, X. Construction of smart stimuli-responsive DNA nanostructures for biomedical applications. Chemistry 27, 3929–3943 (2021).
He, L., Mu, J., Gang, O. & Chen, X. Rationally programming nanomaterials with DNA for biomedical applications. Adv. Sci. 8, 2003775 (2021).
Huang, Z., Qiu, L., Zhang, T. & Tan, W. Integrating DNA nanotechnology with aptamers for biological and biomedical applications. Matter 4, 461–489 (2021).
Smith, D. M. & Keller, A. DNA nanostructures in the fight against infectious diseases. Adv. Nanobiomed. Res. 2000049 (2021).
Lippe, R. Flow virometry: a powerful tool to functionally characterize viruses. J. Virol. 92, e01765–17 (2018).
Zamora, J. L. R. & Aguilar, H. C. Flow virometry as a tool to study viruses. Methods 134–135, 87–97 (2018).
Xia, S. et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res 30, 343–355 (2020).
Nie, J. et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg. Microbes Infect. 9, 680–686 (2020).
Shang, J. et al. Cell entry mechanisms of SARS-CoV-2. Proc. Natl Acad. Sci. USA 117, 11727–11734 (2020).
Koczula, K. M. & Gallotta, A. Lateral flow assays. Essays Biochem 60, 111–120 (2016).
Li, N. et al. Photonic resonator interferometric scattering microscopy. Nat. Commun. 12, 1744 (2021).
Tang, Z. et al. Aptamer switch probe based on intramolecular displacement. J. Am. Chem. Soc. 130, 11268–11269 (2008).
Yip, K. M., Fischer, N., Paknia, E., Chari, A. & Stark, H. Atomic-resolution protein structure determination by cryo-EM. Nature 587, 157–161 (2020).
Nakane, T. et al. Single-particle cryo-EM at atomic resolution. Nature 587, 152–156 (2020).
Zhang, X. et al. Cryo-EM structure of the mature dengue virus at 3.5-A resolution. Nat. Struct. Mol. Biol. 20, 105–110 (2013).
Wadood, A. et al. Epitopes based drug design for dengue virus envelope protein: a computational approach. Comput. Bio. Chem. 71, 152–160 (2017).
Lin, B., Parrish, C. R., Murray, J. M. & Wright, P. J. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202, 885–890 (1994).
Crill, W. D. & Roehrig, J. T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769–7773 (2001).
Sukupolvi-Petty, S. et al. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J. Virol. 81, 12816–12826 (2007).
Gromowski, G. D. & Barrett, A. D. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366, 349–360 (2007).
Lok, S. M. et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat. Struct. Mol. Biol. 15, 312–317 (2008).
Williams, K. L., Wahala, W. M., Orozco, S., de Silva, A. M. & Harris, E. Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology 429, 12–20 (2012).
Dong, Y. et al. DNA functional materials assembled from branched DNA: design, synthesis, and applications. Chem. Rev. 120, 9420–9481 (2020).
Wang, Y. L., Mueller, J. E., Kemper, B. & Seeman, N. C. Assembly and characterization of five-arm and six-arm DNA branched junctions. Biochemistry 30, 5667–5674 (1991).
Fu, T. J. & Seeman, N. C. DNA double-crossover molecules. Biochemistry 32, 3211–3220 (1993).
Wang, X. & Seeman, N. C. Assembly and characterization of 8-arm and 12-arm DNA branched junctions. J. Am. Chem. Soc. 129, 8169–8176 (2007).
Wang, X. et al. Paranemic crossover DNA: there and back again. Chem. Rev. 119, 6273–6289 (2019).
Seeman, N. C. De novo design of sequences for nucleic acid structural engineering. J. Biomol. Struct. Dyn. 8, 573–581 (1990).
He, Y. et al. Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra. Nature 452, 198–201 (2008).
Wang, P. et al. Retrosynthetic analysis-guided breaking tile symmetry for the assembly of complex DNA nanostructures. J. Am. Chem. Soc. 138, 13579–13585 (2016).
Caruthers, M. H. A brief review of DNA and RNA chemical synthesis. Biochem. Soc. Trans. 39, 575–580 (2011).
Roy, S. & Caruthers, M. Synthesis of DNA/RNA and their analogs via phosphoramidite and H-phosphonate chemistries. Molecules 18, 14268–14284 (2013).
Hughes, R. A. & Ellington, A. D. Synthetic DNA synthesis and assembly: putting the synthetic in synthetic biology. Cold Spring Harb. Perspect. Biol. 9, a023812 (2017).
Shlyakhtenko, L. S., Gall, A. A. & Lyubchenko, Y. L. Mica functionalization for imaging of DNA and protein–DNA complexes with atomic force microscopy. Methods Mol. Biol. 931, 295–312 (2013).
Fosmire, J. A., Hwang, K. & Makino, S. Identification and characterization of a coronavirus packaging signal. J. Virol. 66, 3522–3530 (1992).
Kuo, L., Koetzner, C. A. & Masters, P. S. A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging. Virology 494, 100–107 (2016).
Biosafety in Microbiological and Biomedical Laboratories 6th edn (US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, 2020).
Jonsson, U. et al. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11, 620–627 (1991).
van de Loosdrecht, A. A., Beelen, R. H., Ossenkoppele, G. J., Broekhoven, M. G. & Langenhuijsen, M. M. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J. Immunol. Methods 174, 311–320 (1994).
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
Chacon, E., Acosta, D. & Lemasters, J. J. Primary cultures of cardiac myocytes as in vitro models for pharmacological and toxicological assessments. in In Vitro Methods in Pharmaceutical Research 209–223 (Elsevier, 1997).
Patravale, V., Dandekar, P. & Jain, R. Nanoparticulate Drug Delivery: Perspectives on the Transition from Laboratory to Market 123–155 (Elsevier, 2012).
Calisher, C. H., Monath, T. P., Karabatsos, N. & Trent, D. W. Arbovirus subtyping: applications to epidemiologic studies, availability of reagents, and testing services. Am. J. Epidemiol. 114, 619–631 (1981).
Lindsey, H. S., Calisher, C. H. & Mathews, J. H. Serum dilution neutralization test for California group virus identification and serology. J. Clin. Microbiol. 4, 503–510 (1976).
Russell, P. K., Nisalak, A., Sukhavachana, P. & Vivona, S. A plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99, 285–290 (1967).
Abou-Karam, M. & Shier, W. T. A simplified plaque reduction assay for antiviral agents from plants. Demonstration of frequent occurrence of antiviral activity in higher plants. J. Nat. Prod. 53, 340–344 (1990).

Designer DNA nanostructures for viral inhibition

Supplementary information

Supplementary Information

推荐阅读